Hema Biologics
KY - LouisvilleBiotechnology
Focus: Hema Biologics is a newly founded (2024) biotechnology company headquartered in Louisville, KY, focused on bleeding disorder treatments. The company is publicly traded but remains in early-stage development with minimal disclosed pipeline activity.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
12+9 this month
Growing — net +9 jobs in 30d
14 jobs added vs 5 removed. Steady team buildout.
Should You Work at Hema Biologics?
AI assessmentHema Biologics is a high-risk, high-reward early-stage bet suitable only for risk-tolerant professionals seeking startup equity upside in a specialty therapeutic area.
Why Work Here
- Ground-floor opportunity at a newly public biotech company with focused specialty in high-unmet-need bleeding disorders
- 10 active job openings across multiple functions (FT40, Business Development, Quality Assurance) suggest active scaling phase
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Hema Biologics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.